Inventor
Charles A. Dinarello
Inventor
Boulder, CO, US
Overview
Patents· 40 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes25%
C07KPeptides25%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests8%
C12NMicroorganisms or enzymes6%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture4%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
10,723,784Compositions and methods for preparing a subject for organ or non-organ implantation202010,548,870Method for treating multiple sclerosis202010,478,508Compositions, methods and uses for alpha-1 antitrypsin fusion molecules201910,450,384Compositions of alpha-1 antitrypsin fusion molecules20199,938,353Compositions, methods and uses for alpha-1 antitrypsin fusion molecules20189,895,420'IL-1beta propeptide and IL-1Ra chimera and methods of using the same'20189,884,096'Compositions and methods related to graft versus host disease and treatments thereof'20189,522,179'Compositions and methods for modulating cardiac conditions'20169,486,509'Compositions and methods for preparing a subject for organ or non-organ implantation'20169,457,070'Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease'20169,045,559'Method for screening inhibitors of interleukin-32 (IL-32)'20158,754,057'Inhibition of apoptosis-specific eIF-5A(eIF-5A1″) with antisense oligonucleotides and siRNA as anti-inflammatory therapeutics'20148,735,358'Methods for treating cancer by regulation of tumor necrosis factor-alpha'20148,715,649'Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity'20148,637,702'Derivatives of N-hydroxybenzamide for treating HIV infections'20148,436,148'Antibodies against interleukin-18 binding protein, their preparation and use'20138,193,158'Use of apoptosis-specific eIF-5A siRNA to down regulate expression of proinflammatory cytokines to treat sepsis'20128,138,312'Compositions for regulation of tumor necrosis factor-alpha'20127,875,709'Nucleic acids encoding interleukin-18 mutants'20117,820,156'Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine'20107,799,541'Interleukin-18 binding proteins, their preparation and use'20107,741,276'Use of interleukin-18 inhibitors to inhibit tumor metastasis'20107,704,944'Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis'20107,696,154'Methods for treating interleukin-18 mediated disorders with interleukin-18 binding proteins'20107,560,265'Compositions for regulation of tumor necrosis factor-alpha'20097,524,488'Interleukin-18 mutants'20097,279,155'Method of treatment using a cytokine able to bind IL-18BP to inhibit the activity of a second cytokine'20077,220,717'Interleukin-18 binding proteins, their preparation and use'20077,217,517'Nucleic acids, polypeptides, and methods for modulating apoptosis'20077,101,689'Interleukin-18 binding proteins, their preparation and use'20066,605,280'Interleukin-18 binding proteins, their preparation and use for blocking the activity of IL-18'20035,998,578'Biologically active fragments of IL-1.beta.'19995,985,657'Recombinant DNA which codes for interleukin-1'19995,681,933'Antibodies to IL-1.beta.'19975,510,462'IL-1.beta.protein precursor'19965,077,219'Human IL-1 cDNA sequences encoding biologically-active human IL-1 proteins'19915,001,057'Truncated human IL-1 cDNA sequences which encode biologically-active human IL-1 proteins'19914,766,069'Recombinant DNA which codes for interleukin-1 B'19884,762,914'Truncated protein of interleukin-1'19884,434,237'Human leukocytic pyrogen test for the detection of exogenous fever-producing substances'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–2016Patents assigned to DINARELLO CHARLES A (9)· patent assignee history
1984–1991Based in Boston, MA, US· patent location history
1988–1999Patents assigned to TUFTS COLLEGE (7)· patent assignee history
1988–1999Patents assigned to WELLESLEY COLLEGE (7)· patent assignee history
1988–1999Based in Suffolk County, MA, US· patent location history
1999–2020Based in Boulder, CO, US· patent location history
2003–2015Patents assigned to YEDA RES & DEV (8)· patent assignee history
2009–2020Patents assigned to UNIV COLORADO REGENTS (13)· patent assignee history
2012–2020Based in Denver, CO, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV COLORADO REGENTS | 13 | 2009–2020 |
| DINARELLO CHARLES Aself | 9 | 1984–2016 |
| YEDA RES & DEV | 8 | 2003–2015 |
| TUFTS COLLEGE | 7 | 1988–1999 |
| WELLESLEY COLLEGE | 7 | 1988–1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Boulder, CO, US | 28 | 1999–2020 |
| Denver, CO, US | 4 | 2012–2020 |
| Suffolk County, Massachusetts, US | 4 | 1988–1999 |
| Boston, Massachusetts, US | 4 | 1984–1991 |